ROCHE in the news

Inside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambit

Read on: CNBC News

Zealand Pharma says obesity drug deal with Roche will help it stay independent

Read on: Financial Times

Roche to invest $50 billion in US to avoid Trump tariffs

Read on: Daily Sabah

Roche to spend $50bn on US manufacturing and RD

Read on: Financial Times

'Roche could've earned over 100 times what it cost for rare disease drug'

Read on: Times of India

Swiss pharmaceuticals company Roche announces $50B investment in U.S. over next 5 years

Read on: The Washington Times

Roche to invest $50 billion in the U.S. as pharma tariff threat lingers

Read on: CNBC News

Swiss drugmaker Roche to invest $50bn in US in effort to dodge Trump tariffs

Read on: The Guardian

Roche to Invest $50 Billion in Pharma, Diagnostics in US.com

Read on: Bloomberg

Roche descendant Andre Hoffmann on pharma, feuds and family business

Read on: Financial Times

Roche Increases Dividend on Higher Sales

Read on: The Wall Street Journal

Roche plans to launch drugs and slash development costs

Read on: Financial Times

Roche says weight loss drug shows promising results in early trial

Read on: CNBC News

Roche Climbs After Weight-Loss Drug Shows Efficacy

Read on: The Wall Street Journal

Roche says obesity drug results 'encouraging' as competition heats up

Read on: Financial Times

Roche cuts drug pipeline in effort to revitalise business

Read on: Financial Times

Roche to Meet Full-Year Hopes as Sales Beat Forecasts

Read on: The Wall Street Journal

Roche Earnings Miss Views

Read on: The Wall Street Journal

Roche enters obesity market with Carmot takeover but drugs may not be available until 2030

Read on: CNBC News